Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market – Industry Trends and Forecast to 2029

Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market, By Product (Argon, Carbon Dioxide YAG Laser, Diode Laser, Others),  Medium Base (Gas, Liquid, Solid), Modality (Table Top, Fixed, Trolley Mounted),Application (Holmium Laser Enucleation Of The Prostate (HOLEP), Holmium Laser Ablation Of The Prostate (HOLAP), Photoselective Vaporization Of The Prostate (PVP)),  End User (Ambulatory Surgical Centres (ASC), Urology Centre, Hospitals, Speciality Clinics, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size

Benign prostatic hyperplasia (BPH) refers to a condition where the prostate gets enlarged or it could be defined as a noncancerous increase in the size of the prostate gland. Various several different types of prostate laser surgery, such as Holmium laser ablation of the prostate (HoLAP), Holmium laser enucleation of the prostate (HoLEP) and Photoselective vaporization of the prostate (PVP).

• Symptoms may include trouble starting to urinate, inability to urinate, frequent urination and weak stream. Global laser benign prostatic hyperplasia (BPH) devices market was valued at USD 456.62 million in 2021 and is expected to reach USD 781.61 million by 2029, registering a CAGR of 6.60% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

The benign prostatic hyperplasia (BPH) treatment devices refer to the equipment that are utilized in prostate laser surgery. Various type of prostate laser surgery are performed to treat benign prostatic hyperplasia (BPH) condition.

Laser Benign Prostatic Hyperplasia (BPH) Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Growth of Geriatric Population

The ageing population is more prone to the development of benign prostatic hyperplasia (BPH) acts as one of the major factors driving the growth of laser benign prostatic hyperplasia (BPH) devices market.

• Government Investments

The increase in the funding by the federal government to drive the adoption of these devices further influence the market.

• Awareness Programs

The rise in the number of awareness programs amongst the physicians and the patients regarding the necessity to avail the benefits of the laser BPH devices accelerate the market growth.

Additionally, surge in investments, increase in in number of awareness campaigns, and surge in disposable income positively affect the laser benign prostatic hyperplasia (BPH) devices market.

Opportunities

Furthermore, increase in the adoption of the minimally invasive procedures to ensure quicker recovery extend profitable opportunities to the market players in the forecast period of 2022 to 2029.

Restraints/Challenges

On the other hand, high cost associated with these devices is expected to obstruct market growth. Also, lack of reimbursement is projected to challenge the laser benign prostatic hyperplasia (BPH) devices market in the forecast period of 2022-2029.

This laser benign prostatic hyperplasia (BPH) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the laser benign prostatic hyperplasia (BPH) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Laser Benign Prostatic Hyperplasia (BPH) Devices Market

During the outbreak of COVID-19, the demand for various equipment increased as they can be used in the management of the infected people. The need for medical supplies among, both from healthcare professionals and civil population escalated with the rise in number of COVID-19 cases for taking all the precautionary measures.

Recent Development

• Olympus, a global technology leader for medical and surgical procedures expanded urological portfolio during the American Urological Association's (AUA) virtual annual meeting in September’2021. Products featured during virtual annual meeting included the minimally invasive procedure for the treatment of enlarged prostate, SOLTIVE™ SuperPulsed Laser System for treating kidney and ureteral stones.

Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Scope and Market Size

The laser benign prostatic hyperplasia (BPH) devices market is segmented on the basis of product, medium base, modality, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Argon
• Carbon Dioxide Yag Laser
• Diode Laser
• Others

Based on product, laser benign prostatic hyperplasia (BPH) devices market is segmented into argon, carbon dioxide yag laser, diode laser and others.

Medium Base

• Gas
• Liquid
• Solid

On the basis of medium base, laser benign prostatic hyperplasia (BPH) devices market is segmented into gas, liquid and solid.

Modality

• Table Top
• Fixed
• Trolley Mounted

Based on modality, laser benign prostatic hyperplasia (BPH) devices market is segmented into table top, fixed and trolley mounted.

Application

• Holmium Laser Enucleation Of The Prostate (HOLEP)
• Holmium Laser Ablation Of The Prostate (HOLAP)
• Photoselective Vaporization Of The Prostate (PVP)

On the basis of application, laser benign prostatic hyperplasia (BPH) devices market is segmented into holmium laser enucleation of the prostate (HOLEP), holmium laser ablation of the prostate (HOLAP) and photoselective vaporization of the prostate (PVP)

End User

• Ambulatory Surgical Centres (ASC)
• Urology Centre
• Hospitals
• Speciality Clinics
• Others

Laser BPH devices market has also been segmented based on the end user into ambulatory surgical centres (ASC), urology centre, hospitals, speciality clinics and others.

Laser Benign Prostatic Hyperplasia (BPH) Devices Market Regional Analysis/Insights

The laser benign prostatic hyperplasia (BPH) devices market is analysed and market size insights and trends are provided by country, product, medium base, modality, application and end user as referenced above.

The countries covered in the laser benign prostatic hyperplasia (BPH) devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the laser benign prostatic hyperplasia (BPH) devices market because of the presence of aging patients with chronic illnesses within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in disposable income in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The laser benign prostatic hyperplasia (BPH) devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for laser benign prostatic hyperplasia (BPH) devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the laser benign prostatic hyperplasia (BPH) devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share Analysis

The laser benign prostatic hyperplasia (BPH) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to laser benign prostatic hyperplasia (BPH) devices market.

Some of the major players operating in the laser benign prostatic hyperplasia (BPH) devices market are Endo Pharmaceuticals Inc. (Ireland), KARL STORZ SE & Co. KG (Germany), Lumenis. (Israel), Olympus Winter & IBE GMBH (Germany), Urologix, LLC. (US), Boston Scientific Corporation (US), LISA Laser USA (US), ProArc Medical (Israel), Urovision-Urotech (Germany), Teleflex Incorporated. (US), Richard Wolf GmbH. (Germany), BD (US), biolitec AG (Germany), Coloplast Corp (Denmark), among other.